• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • Medical Devices Listing in Hong Kong
  • Overseas Marketing Approvals for Listing Medical Devices in Hong Kong

Overseas Marketing Approvals for Listing Medical Devices in Hong Kong

Friday, 13 March 2020 / Published in Medical Devices Listing in Hong Kong

Overseas Marketing Approvals for Listing Medical Devices in Hong Kong

On 22.01.2020, the Hong Kong MDD (Medical Device Division) announced the continuance of the pilot phase to study the feasibility for LRP (Local Responsible Persons) to apply the MDACS listing of Class II/III/IV general medical devices in Hong Kong by presenting valid marketing approvals obtained from the China NMPA (National Medical Products Administration). The trial started on 01.06.2018, and will last until 31.12.2020.

Currently, there is also another pilot phase that will last until 31.03.2020 for the MDACS listing of Class II/III/IV general medical devices in Hong Kong by presenting valid marketing approvals obtained from the Ministry of Food and Drug Safety of Korea. Other overseas marketing approvals may also be considered applicable in Hong Kong. Consult us to know more.

On 06.11.2019, the Central Government of PRC has accepted the HKSAR government’s proposal for the use of Hong Kong registered pharmaceutical products and common medical devices in designated Hong Kong-owned medical institutions in the Greater Bay Area.

As a facilitation measure for Hong Kong residents working and living in the Greater Bay Area to seek healthcare services, it will help attract local and multinational pharmaceutical, biomedical and health technology companies to introduce medical devices to Hong Kong with a view to expanding their businesses in Hong Kong and Mainland cities in the Greater Bay Area, benefiting patients in both places.

The Food and Health Bureau will be in discussion with relevant Mainland authorities on the implementation details, including the measure at the University of Hong Kong-Shenzhen Hospital on a pilot basis.

Learn more about how Cisema can support you with the Hong Kong MDACS registration.

What you can read next

Importing Drugs and Medical Devices for Urgent Clinical Use in GBA
contract manufacturing of Hong Kong medical device and drug in GBA
Contract manufacturing of Hong Kong medical device and drug in GBA supported by China NMPA
Implementation of Hong Kong-Registered Pharmaceutical Products and Common Medical Devices in China’s Greater Bay Area

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.